Stockreport

NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing [Yahoo! Finance]

NLS Pharmaceutics Ltd. - Common Shares  (NLSP) 
PDF biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces [Read more]